止8月30日,據(jù)財(cái)新統(tǒng)計(jì),在已經(jīng)披露半年報(bào)的上市疫苗企業(yè)中,艾美疫苗、萬(wàn)泰生物、沃森生物、華蘭生物、歐林生物等企業(yè)業(yè)績(jī)均同比出現(xiàn)明顯下滑。 國(guó)內(nèi)疫苗可分為免疫規(guī)劃苗和非免疫規(guī)劃苗,即一類苗和二類苗。一
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million
熱評(píng):
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 562.1
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 382.4
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 1.2 billion
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 1.1 billion
圖片
視頻
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million
熱評(píng):
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 562.1
熱評(píng):
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 382.4
熱評(píng):
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan
熱評(píng):
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 519.6 million
熱評(píng):
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 1.2 billion
熱評(píng):
Hualan Biological Bacterin Inc. (華蘭生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million
熱評(píng):
Hualan Biological Engineering,Inc. (華蘭生物工程股份有限公司) (002007.SZ) reported a net profit of 1.1 billion
熱評(píng):